Clinical Trial Update: An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

View source ↗

Summary

A non-US clinical trial is currently recruiting to evaluate treatment persistence with risankizumab in adults with psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Psoriatic Arthritis | Status: RECRUITING